Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Aprikyan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Seminars in Hematology|April 17, 2002
Cyclic neutropeniaDavid C Dale, Audrey Anna Bolyard, Andrew Aprikyan
Journal of Leukocyte Biology|July 30, 2017
Elastase inhibitors as potential therapies for <i>ELANE</i>-associated neutropeniaVahagn Makaryan, Merideth L Kelley, Breanna Fletcher, et al.
Blood|August 13, 2011
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndromeDavid C Dale, Audrey Anna Bolyard, Merideth L Kelley, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Seminars in Hematology|April 17, 2002
Cyclic neutropeniaDavid C Dale, Audrey Anna Bolyard, Andrew Aprikyan
Journal of Leukocyte Biology|July 30, 2017
Elastase inhibitors as potential therapies for <i>ELANE</i>-associated neutropeniaVahagn Makaryan, Merideth L Kelley, Breanna Fletcher, et al.
Blood|August 13, 2011
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndromeDavid C Dale, Audrey Anna Bolyard, Merideth L Kelley, et al.
Pageof 1